Results 81 to 90 of about 13,200 (163)

HPV‐6 Positive Eruptive Verruca Vulgaris After Upadacitinib Initiation for Severe Atopic Dermatitis

JEADV Clinical Practice, Volume 5, Issue 3, Page 974-978, September 2026.
ABSTRACT Oral JAK‐1 inhibitors for atopic dermatitis (AD) are associated with an increased risk of cutaneous viral infections, particularly herpes zoster. Emerging case reports further suggest a link to eruptive human papillomavirus (HPV) disease. A 23‐year‐old transgender man (female‐to‐male) with severe AD developed a rapidly disseminating eruption ...
Mohammed Shanshal, Emily Moon, Georgios Kallikas   +2 more
wiley   +1 more source

Single-dose desloratadine and montelukast and allergen-induced late airway responses

, 2009
Montelukast and desloratadine synergistically inhibit the allergen-induced early asthmatic response. Montelukast also suppresses the allergen-induced late asthmatic response, but there are no reports on the effect of desloratadine or the combination on ...
Watson, R. M., R. M. Watson, L. P. Boulet, Illamperuma, C., Davis, B. E., F. Deschesnes, B. E. Davis, P. M. O'Byrne, Deschesnes, F., C. Illamperuma, Cockcroft, D. W., Gauvreau, G. M., D. W. Cockcroft, O'Byrne, P. M., Boulet, L. P., G. M. Gauvreau   +15 more
core   +1 more source

Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF

, 2021
Montelukast is a selective leukotriene receptor antagonist that is widely used to treat bronchial asthma and nasal allergy. To clarify the association between montelukast and neuropsychiatric adverse events (AEs), we evaluated case reports recorded ...
Eiichi Hinoi (301857), Noriaki Takeyama (11855618), Masatoshi Inden (619761), Natsumi Ueda (3207462), Yuri Nishibata (4710309), Mizuki Tanaka (4636117), Mitsuhiro Nakamura (308371), Ryogo Umetsu (4710310), Hiroyuki Tanaka (9428), Kiyoka Matsumoto (7474502), Kazuhiro Iguchi (5327258), Yoko Nakayama (11855615), Yamato Kato (4710306), Naoki Inagaki (9429), Shiori Hasegawa (2802643), Yoshinori Muto (11855639)   +15 more
core   +1 more source

A Double-Blind Non-inferiority Clinical Study of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Compared with Pranlukast in Patients with Seasonal Allergic Rhinitis

Allergology International, 2008
Background: During the course of development of montelukast, a cysteinyl leukotriene receptor 1 antagonist, for treatment of seasonal allergic rhinitis, a double-blind, non-inferiority study was carried out to evaluate the efficacy and safety of ...
Kimihiro Okubo, Kohtaro Baba
doaj   +1 more source

MONTELUKAST IN TREATING ALLERGIC DISEASES

, 2006
Anti inflammatory medications are the basis for pathogenetic treatment of allergic diseases. The review covers description of the most studied and efficient medication of leukotriene receptors' antagonist category montelukast.
T.V. Kulichenko
core   +1 more source

Montelukast sodium-induced hypomania

, 2015
Objective: A rare case of induced hypomania was reported. Method: Patient was a 78-year-old Indian female with squamous cell carcinoma of the nasal septum, childhood bronchial asthma and underlying bipolar disorder.
Azhanie Sardangi
core  

Anti-enzymatic and DNA docking studies of montelukast: A multifaceted molecular scaffold with in vitro investigations, molecular expression analysis and molecular dynamics simulations

Heliyon
Montelukast, an approved leukotriene receptor 1 (Cys-LT 1) antagonist with anti-inflammatory properties is used for the treatment of asthma and allergic rhinitis. In the present studies, montelukast was subjected to in vitro inhibitory assays followed by
Shawana Abdullah, Ambar Iqbal, Avinash Karkada Ashok, Farah Chafika Kaouche, Misbah Aslam, Safdar Hussain, Jameel Rahman, Muhammad Munawar Hayat, Muhammad Ashraf   +8 more
doaj   +1 more source

Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma [PDF]

Background: The evidence base on montelukast-associated adverse outcomes is inconclusive in children and young persons (CYP) with asthma. We aimed to investigate 1-year incidence of neuropsychiatric diagnoses after initiation of montelukast as an adjunct
Thompson, Courtney, Herttua, Kimmo, Forton, Julian T, Forton, Julian T., Luciano, Sierra, Fazel, Seena, Paljarvi, Tapio   +6 more
core   +1 more source

Effect of montelukast on remission maintenance in patients with ulcerative colitis: a Randomized, double-blind controlled clinical trial

BMC Gastroenterology
Background Considering the role of leukotrienes in inflammatory pathways, and owing to the anti-leukotrienes effect of montelukast, in the present clinical trial, we aimed to assess the effect of montelukast on remission maintenance in patients with ...
Kourosh Masnadi Shirazi, Mehran Nezam Diba, Arman Masnadi Shirazinezhad, Zeinab Nikniaz   +3 more
doaj   +1 more source

Relationship Between Gender and the Effectiveness of Montelukast: An Italian/Danish Register-Based Retrospective Cohort Study

Frontiers in Pharmacology, 2018
Rationale: Gender-related differences in asthma prevalence, pathophysiology and clinical features induced by sex steroids have been investigated, however, how gender influences response to asthma treatments in routine clinical practice have not yet been ...
Maurizio Sessa, Maurizio Sessa, Annamaria Mascolo, Bruno D'Agostino, Antonio Casciotta, Vincenzo D'Agostino, Fausto De Michele, Mario Polverino, Giuseppe Spaziano, Mikkel Porsborg Andersen, Kristian Kragholm, Kristian Kragholm, Kristian Kragholm, Francesco Rossi, Christian Torp-Pedersen, Christian Torp-Pedersen, Annalisa Capuano   +16 more
doaj   +1 more source